Forbes.com: Genomic Stocks Are in the First Inning of a Multi-Year Megatrend

A recent article in Forbes.com further reinforces the excitement and investment interest in genomic-focused companies. We at GATC Health feel that we are at the ground level of what will be a paradigm shift in scientific discovery for human biology.

From the article: “Breakthroughs in this field will ultimately allow billions of people to live longer and healthier lives. And the companies that make this happen will reap fortunes. Investors who understand this stand to make a fortune in the coming years. Of course, none of this was possible until recently.” Read the full article here

Disclaimer The information set forth herein is presented for informational purposes only and should not be deemed an offer to sell securities.  This presentation contains information which the Company believes to be correct, including certain financial information and projections, but the Company does not guarantee as to the accuracy or completeness of such information.  The Company reserves the right to modify or amend the information contained herein.